Vaughan David Investments LLC Bristol Myers Squibb CO Transaction History

Vaughan David Investments LLC

  • $4.23 Billion
  • Q4 2024

A detailed history of Vaughan David Investments LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Vaughan David Investments LLC holds 7,856 shares of BMY stock, worth $431,922. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,856
Previous 7,777 1.02%
Holding current value
$431,922
Previous $402,000 10.45%
% of portfolio
0.01%
Previous 0.01%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 04, 2025
BUY
$51.92 - $59.94 $4,101 - $4,735
79 Added 1.02%
7,856 $444,000
Q3 2024

Nov 04, 2024
SELL
$39.66 - $51.75 $2.05 Million - $2.68 Million
-51,801 Reduced 86.95%
7,777 $402,000
Q2 2024

Aug 07, 2024
SELL
$40.25 - $52.99 $21.4 Million - $28.1 Million
-530,950 Reduced 89.91%
59,578 $2.47 Million
Q1 2024

May 13, 2024
BUY
$47.98 - $54.4 $58,679 - $66,531
1,223 Added 0.21%
590,528 $32 Million
Q4 2023

Jan 29, 2024
SELL
$48.48 - $57.85 $1.14 Million - $1.36 Million
-23,497 Reduced 3.83%
589,305 $30.2 Million
Q3 2023

Nov 07, 2023
BUY
$57.89 - $64.73 $1.01 Million - $1.13 Million
17,508 Added 2.94%
612,802 $35.6 Million
Q2 2023

Aug 02, 2023
BUY
$63.71 - $70.74 $593,522 - $659,013
9,316 Added 1.59%
595,294 $38.1 Million
Q1 2023

May 02, 2023
BUY
$65.71 - $74.53 $9,593 - $10,881
146 Added 0.02%
585,978 $40.6 Million
Q4 2022

Feb 07, 2023
BUY
$68.48 - $81.09 $1.81 Million - $2.14 Million
26,382 Added 4.72%
585,832 $42.2 Million
Q3 2022

Nov 14, 2022
BUY
$0.13 - $76.84 $686 - $405,715
5,280 Added 0.95%
559,450 $39.8 Million
Q2 2022

Aug 11, 2022
BUY
$72.62 - $79.98 $446,903 - $492,196
6,154 Added 1.12%
554,170 $42.7 Million
Q1 2022

May 09, 2022
BUY
$61.48 - $73.72 $348,099 - $417,402
5,662 Added 1.04%
548,016 $40 Million
Q4 2021

Feb 10, 2022
BUY
$53.63 - $62.52 $409,733 - $477,652
7,640 Added 1.43%
542,354 $33.8 Million
Q3 2021

Nov 04, 2021
SELL
$59.17 - $69.31 $96,092 - $112,559
-1,624 Reduced 0.3%
534,714 $31.6 Million
Q2 2021

Aug 11, 2021
BUY
$61.91 - $67.42 $1.01 Million - $1.11 Million
16,390 Added 3.15%
536,338 $35.8 Million
Q1 2021

May 14, 2021
BUY
$59.34 - $66.74 $602,419 - $677,544
10,152 Added 1.99%
519,948 $32.8 Million
Q4 2020

Feb 12, 2021
BUY
$57.74 - $65.43 $681,793 - $772,597
11,808 Added 2.37%
509,796 $31.6 Million
Q3 2020

Nov 12, 2020
BUY
$57.43 - $63.64 $115,434 - $127,916
2,010 Added 0.41%
497,988 $30 Million
Q2 2020

Aug 07, 2020
BUY
$54.82 - $64.09 $411,040 - $480,546
7,498 Added 1.53%
495,978 $29.2 Million
Q1 2020

May 13, 2020
BUY
$46.4 - $67.43 $568,400 - $826,017
12,250 Added 2.57%
488,480 $27.2 Million
Q4 2019

Feb 13, 2020
BUY
$49.21 - $64.19 $267,899 - $349,450
5,444 Added 1.16%
476,230 $30.6 Million
Q3 2019

Nov 13, 2019
BUY
$42.77 - $50.71 $473,806 - $561,765
11,078 Added 2.41%
470,786 $23.9 Million
Q2 2019

Aug 14, 2019
BUY
$44.62 - $49.34 $20 Million - $22.1 Million
448,868 Added 4140.85%
459,708 $20.8 Million
Q1 2019

May 08, 2019
SELL
$45.12 - $53.8 $5,233 - $6,240
-116 Reduced 1.06%
10,840 $517,000
Q4 2018

Feb 08, 2019
BUY
$48.76 - $63.23 $40,422 - $52,417
829 Added 8.19%
10,956 $569,000
Q2 2018

Aug 14, 2018
SELL
$50.53 - $62.98 $41,889 - $52,210
-829 Reduced 7.57%
10,127 $560,000
Q1 2018

May 04, 2018
SELL
$59.92 - $68.98 $41,944 - $48,286
-700 Reduced 6.01%
10,956 $693,000
Q4 2017

Feb 13, 2018
SELL
$59.94 - $65.35 $45,494 - $49,600
-759 Reduced 6.11%
11,656 $714,000
Q3 2017

Nov 09, 2017
SELL
$55.23 - $63.74 $23.1 Million - $26.7 Million
-418,908 Reduced 97.12%
12,415 $791,000
Q3 2017

Nov 08, 2017
BUY
$55.23 - $63.74 $23.1 Million - $26.7 Million
418,108 Added 3163.89%
431,323 $13.7 Million
Q2 2017

Aug 14, 2017
BUY
N/A
13,215
13,215 $736,000

Others Institutions Holding BMY

# of Institutions
2,749
Shares Held
1.57B
Call Options Held
28M
Put Options Held
28.7M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $117B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Vaughan David Investments LLC Portfolio

Follow Vaughan David Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vaughan David Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vaughan David Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email